| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.46.5.1591-1593.2002 |
| P8608 | Fatcat ID | release_5b4xoktizzclhjdys6jeggqbry |
| P932 | PMC publication ID | 127149 |
| P698 | PubMed publication ID | 11959609 |
| P50 | author | Cedric Jacqueline | Q41005532 |
| P2093 | author name string | N Asseray | |
| J Caillon | |||
| N Roux | |||
| M F Kergueris | |||
| G Potel | |||
| D Bugnon | |||
| R Bismuth | |||
| P2860 | cites work | Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. | Q33963433 |
| Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review | Q34041400 | ||
| Characterization of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus involved in nosocomial spread | Q34072865 | ||
| Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart | Q34228754 | ||
| Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association | Q34288403 | ||
| Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management | Q34361837 | ||
| A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses | Q34389944 | ||
| Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci | Q35281457 | ||
| Effect of aminoglycoside concentration on reaction rates of aminoglycoside-modifying enzymes | Q35305404 | ||
| Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis | Q35534742 | ||
| Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis | Q35760739 | ||
| Nomenclature of genes encoding aminoglycoside-modifying enzymes | Q42743065 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| In vivo simulation of human pharmacokinetics in the rabbit. | Q52242542 | ||
| Prevalence and mechanisms of aminoglycoside resistance. A ten-year study | Q69561841 | ||
| New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis | Q77457198 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| P304 | page(s) | 1591-1593 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model | |
| P478 | volume | 46 |
| Q44545131 | Aminoglycoside-resistance mechanisms in multidrug-resistant Staphylococcus aureus clinical isolates |
| Q39652231 | Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study |
| Q38693212 | Dose Timing of Aminoglycosides in Hemodialysis Patients: A Pharmacology View |
| Q44964829 | The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model |
| Q53967258 | [Antibiotic combinations in Staphylococcus aureus infections: arguments in favour]. |
Search more.